Skip to main content
logo
Rail Vikas Nigam Limited (NSE:RVNL)
India flag India · Delayed Price · Currency is INR
345.45
-2.70 (-0.78%)
Aug 1, 2025, 3:30 PM IST

Verve Therapeutics Revenue

In the fiscal year ending March 31, 2025, Rail Vikas Nigam had annual revenue of 199.23B INR, down -8.98%. Rail Vikas Nigam had revenue of 64.27B in the quarter ending March 31, 2025, a decrease of -4.28%.

Revenue
199.23B
Revenue Growth
-8.98%
P/S Ratio
3.62
Revenue / Employee
1.07B
Employees
186
Market Cap
720.27B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025199.23B-19.66B-8.98%
Mar 31, 2024218.89B16.08B7.93%
Mar 31, 2023202.82B9.00B4.64%
Mar 31, 2022193.82B39.78B25.82%
Mar 31, 2021154.04B8.73B6.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Hindustan Aeronautics309.81B
Adani Ports and Special Economic Zone304.75B
InterGlobe Aviation820.97B
Mazagon Dock Shipbuilders117.00B
Siemens222.24B
CG Power and Industrial Solutions105.59B
Polycab India236.16B
GMR Airports112.17B
Revenue Rankings

Rail Vikas Nigam News

More News